Based on the Acuren Corporation stock forecast from 1 analysts, the average analyst target price for Acuren Corporation is USD 13.00 over the next 12 months. Acuren Corporation’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Acuren Corporation is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Acuren Corporation’s stock price was USD 10.53. Acuren Corporation’s stock price has changed by +7.12% over the past week, +14.58% over the past month and 0% over the last year.
No recent analyst target price found for Acuren Corporation
No recent average analyst rating found for Acuren Corporation
Company Overview Acuren Corporation
Acuren Corporation provides critical asset integrity services in North America. Its activities include various nondestructive testing (NDT) techniques, such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection. Its NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, avoid accidents, and comply with regulatory requirements without destroying the asset or component. The company also provides market rope access technician solutions, including inspection and testing, as well as insulation, coatings and blasting, welding, pipe fitting, hoisting and rigging, and electrical services. In addition, its TIC service includes support from consulting engineers with in-lab destructive testing capabilities. The company provides support failure investigation, material selection, corrosion engineering, welding engineering, fracture mechanics, destructive testing, and chemical analysis. It serves a various industrial market, primarily chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. Acuren Corporation was founded in 1974 and is headquartered in Tomball, Texas. Read Less
Acuren Corporation provides critical asset integrity services in North America. Its activities include various nondestructive testing (NDT) techniques, such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection. Its NDT activit...Read More
Frequently Asked Questions About Acuren Corporation (TIC) Stock
Based on ratings from 1 analysts Acuren Corporation's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on TIC's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for TIC is USD 13.00 over the next 12 months. The maximum analyst target price is USD 13 while the minimum anlayst target price is USD 13.
TIC stock's Price/Earning ratio is 48.44.
Our analysis grades TIC stock's Price / Earning ratio at F. This means that TIC stock's Price/Earning ratio is above 81% of the stocks in the Engineering & Construction sector in the NYE exchange.
Based on this TIC may be a overvalued for its sector.
The last closing price of TIC's stock was USD 10.53.
The most recent market capitalization for TIC is USD 1.47B.
Based on targets from 1 analysts, the average taret price for TIC is projected at USD 13.00 over the next 12 months.
This means that TIC's stock price may go up by +23.46% over the next 12 months.
We can't find any ETFs which contains Acuren Corporation's stock.
As per our most recent records Acuren Corporation has 5,498 Employees.
Acuren Corporation's registered address is 14434 Medical Complex Drive, Tomball, TX, United States, 77377.
You can get more information about it from Acuren Corporation's website at https://www.acuren.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Acuren Corporation (TIC) Stock
Based on ratings from 1 analysts Acuren Corporation's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on TIC's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for TIC is USD 13.00 over the next 12 months. The maximum analyst target price is USD 13 while the minimum anlayst target price is USD 13.
TIC stock's Price/Earning ratio is 48.44.
Our analysis grades TIC stock's Price / Earning ratio at F. This means that TIC stock's Price/Earning ratio is above 81% of the stocks in the Engineering & Construction sector in the NYE exchange.
Based on this TIC may be a overvalued for its sector.
The last closing price of TIC's stock was USD 10.53.
The most recent market capitalization for TIC is USD 1.47B.
Based on targets from 1 analysts, the average taret price for TIC is projected at USD 13.00 over the next 12 months.
This means that TIC's stock price may go up by +23.46% over the next 12 months.
We can't find any ETFs which contains Acuren Corporation's stock.
As per our most recent records Acuren Corporation has 5,498 Employees.
Acuren Corporation's registered address is 14434 Medical Complex Drive, Tomball, TX, United States, 77377.
You can get more information about it from Acuren Corporation's website at https://www.acuren.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TIC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
